Table 3.
Variable | Timely PCI (<90 min) (N=108) | Delayed PCI (> 90 min) (N=90) | P value |
---|---|---|---|
| |||
First 24 h of admission | |||
Aspirin | 107.0 (99.1) | 88.0 (97.8) | .432 |
Clopidogrel | 107.0 (99.1) | 88.0 (97.8) | .432 |
Loading 600 mg | 74.0 (68.5) | 44.0 (48.9) | .025 |
Beta-blocker | 89.0 (82.4) | 73.0 (81.1) | .478 |
ACEi/ARB | 81.0 (75.0) | 70.0 (77.8) | .387 |
Statin | 107.0 (99.1) | 87.0 (96.7) | .231 |
Prior to PCI | |||
Anticoagulation | 101.0 (93.5) | 79.0 (87.7) | .162 |
GPIIbIIIa inhibitor | 68.0 (55.7) | .0 | .389 |
Type of stents: | |||
BMS | 57.0 (54.3) | 40.0 (50.0) | .738 |
At discharge: | |||
Aspirin | 103.0 (95.3) | 82.0 (91.1) | .260 |
Clopidogrel | 103.0 (95.3) | 82.0 (91.1) | 260 |
Beta-blocker | 98.0 (90.7) | 76.0 (85.4) | .271 |
ACEi/ARB | 83.0 (76.9) | 73.0 (82.0) | .385 |
Statin | 104.0 (96.3) | 80.0 (89.9) | .085 |
Key: ACEi: Angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blocker; GIIbIIIa: glycoprotein 2b-3a inhibitor.